Gefitinib vs Influenza A Virus Hemagglutinin

Gefitinib vs Influenza A Virus Hemagglutinin: Overview

This comparison examines the pharmacological differences between Gefitinib and Influenza A Virus Hemagglutinin.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3.

Molecular Weight: Gefitinib — 446.9000 g/mol.

Type: Gefitinib — Small molecule; Influenza A Virus Hemagglutinin — Vaccine component.